Global disparities in public health guidance for the use of COVID-19 vaccines in pregnancy
Authors:
Open Access
- 24 February 2022
- journal article
- research article
- Published by BMJ in BMJ Global Health
- Vol. 7 (2) , e007730
Abstract
Introduction Gaps in information about the safety and efficacy of COVID-19 vaccines in pregnancy have led to substantial global variation in public health guidance regarding the use of COVID-19 vaccines in pregnancy over the course of the pandemic. Methods We conducted systematic screenings of public health authorities’ websites across 224 countries and territories every 3 weeks to track the development of policies on COVID-19 vaccine use in pregnancy. Policies were categorised using a 1–5 permissiveness scale, with 1 indicating policies that recommended use, and 5 indicating policies that recommended against use. Results As of 30 September 2021, 176 countries/territories had issued explicit guidance on COVID-19 vaccine use in pregnancy, with 38% recommending use, 28% permitting use, 15% permitting use with qualifications, 2% not recommending but with exceptions, and 17% not recommending use whatsoever. This represented a significant shift from May 2021, when only 6% of countries/territories with such policies recommended the use of COVID-19 vaccines in pregnancy (pConclusion Our study highlights the evolution of policies regarding COVID-19 vaccine use in pregnancy over a 5-month period in 2021, the role of pregnancy-specific data in shaping these policies and how inequities in access for pregnant people persist, both within countries and globally.Keywords
Funding Information
- Wellcome (221556/Z/20/Z)
- Bill and Melinda Gates Foundation (INV-016877)
This publication has 23 references indexed in Scilit:
- Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant PersonsNew England Journal of Medicine, 2021
- Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance dataThe Lancet, 2021
- Pregnancy and neonatal outcomes of COVID‐19: coreporting of common outcomes from PAN‐COVID and AAP‐SONPM registriesUltrasound in Obstetrics & Gynecology, 2021
- Pregnant women & vaccines against emerging epidemic threats: Ethics guidance for preparedness, research, and responseVaccine, 2021
- Update: Characteristics of Symptomatic Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status — United States, January 22–October 3, 2020MMWR. Morbidity and Mortality Weekly Report, 2020
- Birth and Infant Outcomes Following Laboratory-Confirmed SARS-CoV-2 Infection in Pregnancy — SET-NET, 16 Jurisdictions, March 29–October 14, 2020MMWR. Morbidity and Mortality Weekly Report, 2020
- Pregnancy Outcomes Among Women With and Without Severe Acute Respiratory Syndrome Coronavirus 2 InfectionJAMA Network Open, 2020
- Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysisBMJ, 2020
- Maternal Mortality From Coronavirus Disease 2019 (COVID-19) in the United StatesObstetrics & Gynecology, 2020
- Protected to death: systematic exclusion of pregnant women from Ebola virus disease trialsReproductive Health, 2017